Figure 4 shows that MIP-1β, IL-6, IL-8, MCP-1, IL-1β, G-CSF, and GM-CSF levels were reduced in the blood of ulcerative colitis patients and MIP-1β, MCP-1, IL-8, IL-1β, G-CSF, IL-17, GM-CSF, and IL-2 levels in blood of Crohn's patients, respectively. This anti-inflammatory property of AbM may also be of importance for the mushroom's therapeutic effect on allergy and asthma in mouse models [18, 21], both of which are inflammatory conditions, and it may bear promise for use against autoimmune diseases. The gene discussed is CCL2; the disease is autoimmune disease.